(Q33379080)

26 July 2017

title

Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia (English)

1 reference

multicenter clinical trial

26 July 2017

main subject

0 references

1 reference

R Herold

2

0 references

author name string

A Karachunskiy

1

1 reference

26 July 2017

A von Stackelberg

3

1 reference

26 July 2017

N Miakova

4

1 reference

26 July 2017

A Timakow

5

1 reference

26 July 2017

T Mahortih

6

1 reference

26 July 2017

L Bajdun

7

1 reference

26 July 2017

A Maschan

8

1 reference

26 July 2017

L Fechina

9

1 reference

26 July 2017

A Shamardina

10

1 reference

26 July 2017

S Dudkin

11

1 reference

26 July 2017

V Lebedev

12

1 reference

26 July 2017

S Varfolomeeva

13

1 reference

26 July 2017

V Timofeeva

14

1 reference

26 July 2017

J Roumiantseva

15

1 reference

26 July 2017

N Chipsanova

16

1 reference

26 July 2017

A Rumjanzew

17

1 reference

26 July 2017

G Henze

18

1 reference

26 July 2017

publication date

27 March 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

22

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

1144-1153

1 reference

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

[Estimation of tumor cell mass in childhood acute lymphoblastic leukemia: prognostic significance and practical application]

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Calculating confidence intervals for survival time analyses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.63

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.63

1 reference

Dimensions Publication ID

26 July 2017

1023710210

0 references

1 reference